Results
1 -
10 of
78Q. Ding, C. Li, L. Wang, Y. Li, H. Zhou, Q. Gu, J. Xu.
7 Current and future pharmacological therapies for NAFLD/NASH, Journal of Gastroenterology Assessment of Pharmacokinetic Interactions Between Obeticholic Acid and Caffeine, Midazolam, Warfarin, Dextromethorphan, Omeprazole, Rosuvastatin, and Digoxin in Phase 1 Studies in Healthy Subjects, Advances in Therapy NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor, Scientific Reports Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease, Alcoholic and Non-Alcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease Treatment, Gastrointestinal Complications of Diabetes Bile Acid-Induced Liver Injury in Cholestasis, Cellular Injury in Liver Diseases Nonalcoholic Fatty Liver Disease, Liver Disorders Potential Antifibrotic Therapies: Approaching the Bedside: Proof-of-Concept Studies (Part 1), Portal Hypertension VI